Trans-esophageal endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) has proven to be a safe and minimally invasive tissue-sampling method which can be used to obtain a cytological diagnosis from mediastinal lesions. The aims of EUS-FNA in the mediastinum are either to diagnose a lesion of unknown origin, to stage mediastinal lymph nodes in lung cancer patients or to diagnose other diseases involving lymph nodes of the mediastinum. In patients with non-small cell lung cancer (NSCLC), surgery may be regarded as futile in up to 45% of patients operated, apparently because the stage of the disease is more advanced than expected preoperatively. This, combined with a stage-dependent multimodality treatment, underlines the importance of exact staging of the disease. Conventional imaging and tissue sampling methods all have variable sensitivities.Twenty-two studies concerning EUS-FNA and mediastinal staging of lung cancer have been published with a total number of 1245 patients. The reported sensitivity for mediastinal malignancy range from 0.61-1.00 (median 0.90), and with specificities of 0.71-1.00 (median 1.00). The majority of the studies are retrospective and present the results of EUS-FNA performed in lung cancer patients selected by computer tomography (CT). Recent data suggests that EUS-FNA in addition can diagnose advanced mediastinal disease in 22-42% of NSCLC patients with normal sized lymph nodes ( < 1 cm) on chest CT. EUS-FNA may also be used as a re-staging procedure after induction chemotherapy and it seems that EUS-FNA is more accurate for mediastinal staging of NSCLC compared to positron emission tomography (PET). However, further studies are necessary before final conclusions can be made. At present, mediastinoscopy is still considered complementary to EUS-FNA because EUS-FNA cannot visualize structures anterior to the air-filled trachea and main bronchi. Endoscopic trans -bronchial real-time ultrasound guided biopsy (EBUS-TBNA) performed via the trachea and main bronchi seems to be an obvious solution. Preliminary experience with a prototype EBUS-TBNA bronchoscope (Olympus, XBF-UC40P, Tokyo, Japan) in 214 patients has shown promising results. Hopefully the combination of EUS-FNA and EBUS-TBNA will be able to replace more invasive and risky staging methods and improve the N-staging accuracy of the mediastinum and lung hilar regions in the near future.Key words: endoscopic ultrasound guided biopsy from lymph nodes in the mediastinum, endosonography guided biopsy of the mediastinum, EUS-FNA, lung cancer staging, staging of NSCLC.